# Participant(s) With Autism and High Pain Tolerance Treated With High Dose Naltrexone

> **NCT05100563** · — · COMPLETED · sponsor: **State University of New York - Upstate Medical University** · enrollment: 1 (actual)

## Conditions studied

- Autism Spectrum Disorder

## Interventions

- **DRUG:** 50 mg naltrexone

## Key facts

- **NCT ID:** NCT05100563
- **Lead sponsor:** State University of New York - Upstate Medical University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-01
- **Primary completion:** 2021-05-24
- **Final completion:** 2021-05-24
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2022-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05100563

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05100563, "Participant(s) With Autism and High Pain Tolerance Treated With High Dose Naltrexone". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05100563. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*